Tumor growth rate as a validated early radiological biomarker able to reflect treatment-induced changes in neuroendocrine tumors: The GREPONET-2 study (2019) Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez CL, Pezzutti D, et al. Journal article A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO) (2019) Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, Mina LA, et al. Journal article A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection (2019) Hess J, Unger K, Maihoefer C, Schuettrumpf L, Wintergerst L, Heider T, Weber P, et al. Journal article Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant geparsepto trial (2019) Loibl S, Treue D, Budczies J, Weber K, Stenzinger A, Schmitt WD, Weichert W, et al. Journal article A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB) (2019) Mayer IA, Prat A, Egle D, Blau S, Alejandro Perez Fidalgo J, Gnant M, Fasching P, et al. Journal article Functional parameters derived from magnetic resonance imaging reflect vascular morphology in preclinical tumors and in human liver metastases (2018) Kannan P, Kretzschmar WW, Winter H, Warren D, Bates R, Allen PD, Syed N, et al. Journal article Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and frequent T-cell targets in human IDH-mutant glioma (2018) Dettling S, Stamova S, Warta R, Schnoelzer M, Rapp C, Rathinasamy A, Reuss D, et al. Journal article Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy (2018) Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, Appold S, et al. Journal article Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor (2018) Loibl S, Weber K, Huober J, Krappmann K, Marme F, Schem C, Engels K, et al. Journal article Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups (2018) Van Kessel KEM, Van Der Keur KA, Dyrskjot L, Algaba F, Welvaart NYC, Beukers W, Segersten U, et al. Journal article